Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients  Hans-Peter Hauber, Inga S Beyer,

Slides:



Advertisements
Similar presentations
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
The prevalence of “risky behaviour” in adults with cystic fibrosis
The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics  Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,
Monocyte chemoattractant chemokines in cystic fibrosis
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis  Annemarie Lee,
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
Cirrhosis and other liver disease in cystic fibrosis
Volume 65, Issue 4, Pages (April 2004)
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
Controlled clinical trials in cystic fibrosis — are we doing better?
Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time  Rosemary Ball, Kevin W. Southern, Pamela.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Alan P Knutsen, Clifford Bellone, Henk Kauffman 
The Journal of Cystic Fibrosis: Sunny perspectives
A.H. Gifford  Journal of Cystic Fibrosis 
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden  Per Kristian Knudsen, Hanne.
Cystic fibrosis related diabetes in an extremely young patient
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis  D.W. Reid, R. Latham, I.L.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson 
Cytokine gene polymorphisms and severity of CF lung disease
Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune.
Nasal polyposis in lung transplant recipients with cystic fibrosis
Increased expression of Interleukin-13 but not Interleukin-4 in cystic fibrosis patients  Hans-Peter Hauber, Djalal Gholami, Gerhard Koppermann, Hans-Eberhard.
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale 
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Stability of interleukin 8 and neutrophil elastase in bronchoalveolar lavage fluid following long-term storage  Luke J. Berry, Barbara Sheil, Luke Garratt,
Erythromycin improves gastric emptying half-time in adult cystic fibrosis patients with gastroparesis  Adriano R. Tonelli, Walter E. Drane, Dennis P.
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
Volume 60, Issue 6, Pages (December 2001)
L. Uppaluri, S.J. England, T.F. Scanlin  Journal of Cystic Fibrosis 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Ristan M. Greer, Helen M. Buntain, Peter J. Lewindon, Claire E
Beta-lactam allergy in adults with cystic fibrosis
N Dauletbaev, K Viel, R Buhl, T.O.F Wagner, J Bargon 
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Interleukin-17A Promotes IgE Production in Human B Cells
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
H. White, A.M. Morton, D.G. Peckham, S.P. Conway 
Presentation transcript:

Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients  Hans-Peter Hauber, Inga S Beyer, Andreas Meyer, Almuth Pforte  Journal of Cystic Fibrosis  Volume 3, Issue 2, Pages 129-131 (June 2004) DOI: 10.1016/j.jcf.2004.03.006

Fig. 1 Semiquantitative PCR analysis of IL-18 mRNA (A) and IL-10 mRNA (B) expression in BAL cells and PBMC of patients and control subjects. Columns represent mean values (+S.E.M.). *p<0.05 vs. control. Journal of Cystic Fibrosis 2004 3, 129-131DOI: (10.1016/j.jcf.2004.03.006)

Fig. 2 Effect of IL-10 stimulation on PBMC of patients. Columns represent mean values (+S.E.M.) of semiquantitative PCR analysis. *p<0.05 vs. unstimulated. Journal of Cystic Fibrosis 2004 3, 129-131DOI: (10.1016/j.jcf.2004.03.006)